LCN2 and breast cancer: Several studies have observed high levels of LCN2 associated with MMP-9 as a heterodimer in the urine of breast cancer patients, in high-grade endometrial cancer tissues, and in cell lysates of oral squamous carcinoma cell lines [35,43,75].